Musk’s lawsuit against OpenAI, Microsoft heads to April jury trial
Musk’s lawsuit against OpenAI, Microsoft heads to April jury trial
Source link
Similar Posts
Tuesday: Employment Report, Retail Sales
by Calculated Risk on 12/15/2025 07:36:00 PM From Matthew Graham at Mortgage News Daily: Mortgage Rates Slightly Lower as Volatility Risks Increase Mortgage rates were just slightly lower to start the new week. This leaves the average lender’s top tier 30yr fixed rate almost dead center in the narrow range that’s been intact since early…
Conagra Brands, Inc. (CAG) Q3 2026 Earnings Call Prepared Remarks Transcript
Follow Q3: 2026-04-01 Earnings Summary EPS of $0.39 misses by $0.01 | Revenue of $2.79B (-1.87% Y/Y) beats by $27.40M Conagra Brands, Inc. (CAG) Q3 2026 Earnings Call March 31, 2026 8:00 PM EDT Company Participants Matthew Neisius – Senior Director of Investor RelationsSean Connolly – President, CEO & Director David Marberger – Executive VP &…
Mcap of 8 of top-10 most valued firms jumps Rs 4.13 lakh cr; HDFC, ICICI Bank top gainers
The combined market valuation of eight of the top-10 most valued firms surged by Rs 4,13,003.23 crore last week, with HDFC Bank and ICICI Bank emerging as the biggest gainers, in tandem with an optimistic trend in equities. Last week, the BSE benchmark Sensex jumped 4,230.7 points or 5.77 per cent, and the NSE Nifty…
TCS Partners with Odisha Govt for New Financial System, Shares End 1.5% Lower
September 5, 2025September 5, 2025 Shares of Tata Consultancy Services Ltd (TCS) ended 1.5% lower after touching a day’s high of Rs 3,103.40 on 5th September, despite the firm saying it has partnered with the Odisha government to design and implement an integrated financial management system (IFMS) 3.0. TCS…
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds
Blood test-guided treatment with AstraZeneca pill cut risk of breast cancer progression, study finds Source link
